bioRxivBioengineeringPreprint
Anti Alzheimer's effects of Neem oil nanoemulsion against Amyloid β1-40 induced in human neuroblastoma SH-SY5Y cell line
Abstract
Alzheimers disease is characterized by cognitive decline associated with neurodegeneration and accumulation of amyloid beta. Here, experimenting with in vitro models of AD using SHSY5Y cell line after exposing them with A{beta}1-40. The natural derivatives like neem oil, plays a potential role in neuroprotection and reduction of tau aggregates in animal models, eventually becoming a alternative treatment beneficiaries in neurodegenerative disease. Formulating the neem oil into a nanoemulsion with Tween 80(R) and Brij 30 for stabilization, can be a beneficial drug development for AD. The optimization of this neem oil nanoemulsion was performed with Response Surface Methodology - Box Behnken Design, showed the S mix 10, Sonication power 55%, and Sonication time 15%; as the optimized value to synthesize a stable neem oil nanoemulsion. Secondly, they subjected to thermodynamic stability analysis for estimating the shelf life duration with different temperature conditions. Amyloid beta induced SHSY5Y tend to show severe cell oxidative stress, to estimate that, the neem oil and neem oil nanoemulsion were subjected to DPPH assay. Further, the neem oil and neem oil nanoemulsion analyzed with the A{beta}1-40 induced SHSY5Y, resulted in good cytotoxicity, where the nanoemulsion exhibited more reduction in cell viability than neem oil. This trend shows that synthesizing the natural oils into nanocarriers can potentially increase the drug release rate, enhanced stability and good biomedical application
- Citations
- 2
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Naphthalene monoimide derivative ameliorates amyloid burden and cognitive decline in a transgenic mouse model of Alzheimer's disease
Sourav Samanta, Kolla Rajasekhar, … Thimmaiah Govindaraju·Advanced TherapeuticsPeer-reviewed·Jan 28, 2021
- Investigating TRSV Phytoalexin Infusions as a Novel Treatment for Alzheimer's Disease Using ApoE4 Plasmid Transfections in Neuro2a Cell Complexes
Om Gandhi·Archives in Neurology & NeurosciencePeer-reviewed·May 12, 2020
- Neuroprotection by chronic administration of Fluoroethylnormemantine (FENM) in mouse models of Alzheimer's disease
Allison Carles, Aline Freyssin, … Tangui Maurice·Alzheimer s Research & TherapyPeer-reviewed·Jan 6, 2025
- Zhi-Shi-Wu-Huang attenuates amyloid beta toxicity in Caenorhabditis elegans Alzheimer's disease models via modulating insulin DAF-16 signaling pathway
Fahim Muhammad, Yan Liu, … Hongyu Li·bioRxiv·Mar 10, 2026
- EVALUATION OF TAURINE'S NEUROPROTECTIVE EFFECTS ON SH-SY5Y CELLS UNDER OXIDATIVE STRESS
R. C. Rossato, A. E. C. Granato, … C. P. Soares·bioRxiv·Apr 26, 2021
- Comprehensive characterization of the neurogenic and neuroprotective action of a novel TrkB agonist using mouse and human stem cell models of Alzheimer's Disease
D. Charou, T. Rogdakis, … I. Charalampopoulos·bioRxiv·May 8, 2023